Cargando…

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Detalles Bibliográficos
Autores principales: Wong, Yu Jun, Sharma, Sanchit, Tosetti, Giulia, Qi, Xiaolong, Primignani, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845681/
https://www.ncbi.nlm.nih.gov/pubmed/36642415
http://dx.doi.org/10.3350/cmh.2022.0408
_version_ 1784870962387222528
author Wong, Yu Jun
Sharma, Sanchit
Tosetti, Giulia
Qi, Xiaolong
Primignani, Massimo
author_facet Wong, Yu Jun
Sharma, Sanchit
Tosetti, Giulia
Qi, Xiaolong
Primignani, Massimo
author_sort Wong, Yu Jun
collection PubMed
description
format Online
Article
Text
id pubmed-9845681
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-98456812023-01-31 Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients” Wong, Yu Jun Sharma, Sanchit Tosetti, Giulia Qi, Xiaolong Primignani, Massimo Clin Mol Hepatol Correspondence The Korean Association for the Study of the Liver 2023-01 2022-11-22 /pmc/articles/PMC9845681/ /pubmed/36642415 http://dx.doi.org/10.3350/cmh.2022.0408 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Wong, Yu Jun
Sharma, Sanchit
Tosetti, Giulia
Qi, Xiaolong
Primignani, Massimo
Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title_full Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title_fullStr Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title_full_unstemmed Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title_short Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
title_sort correspondence on editorial regarding “baveno-vii criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845681/
https://www.ncbi.nlm.nih.gov/pubmed/36642415
http://dx.doi.org/10.3350/cmh.2022.0408
work_keys_str_mv AT wongyujun correspondenceoneditorialregardingbavenoviicriteriatopredictdecompensationandinitiatenonselectivebetablockerincompensatedadvancedchronicliverdiseasepatients
AT sharmasanchit correspondenceoneditorialregardingbavenoviicriteriatopredictdecompensationandinitiatenonselectivebetablockerincompensatedadvancedchronicliverdiseasepatients
AT tosettigiulia correspondenceoneditorialregardingbavenoviicriteriatopredictdecompensationandinitiatenonselectivebetablockerincompensatedadvancedchronicliverdiseasepatients
AT qixiaolong correspondenceoneditorialregardingbavenoviicriteriatopredictdecompensationandinitiatenonselectivebetablockerincompensatedadvancedchronicliverdiseasepatients
AT primignanimassimo correspondenceoneditorialregardingbavenoviicriteriatopredictdecompensationandinitiatenonselectivebetablockerincompensatedadvancedchronicliverdiseasepatients